Bruce Pollock - Publications

Affiliations: 
University of Toronto (CAMH), Toronto, Ontario, Canada 

68 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Ismail M, Straubinger T, Uchida H, Graff-Guerrero A, Nakajima S, Suzuki T, Caravaggio F, Gerretsen P, Mamo D, Mulsant BH, Pollock BG, Bies R. "MAP Bayesian modeling combining striatal dopamine receptor occupancy and plasma concentrations to optimize antipsychotic dose regimens in individual patients". British Journal of Clinical Pharmacology. PMID 35112390 DOI: 10.1111/bcp.15260  0.555
2021 Kish SJ, O'Leary G, Mamelak M, McCluskey T, Warsh JJ, Shapiro C, Bies R, Yu Y, Pollock B, Tong J, Boileau I. Does sodium oxybate inhibit brain dopamine release in humans? An exploratory neuroimaging study. Human Psychopharmacology. e2791. PMID 33899252 DOI: 10.1002/hup.2791  0.486
2020 Reeves S, Bertrand J, Uchida H, Yoshida K, Otani Y, Ozer M, Liu KY, Bramon E, Bies R, Pollock BG, Howard R. Towards safer risperidone prescribing in Alzheimer's disease. The British Journal of Psychiatry : the Journal of Mental Science. 1-8. PMID 33176899 DOI: 10.1192/bjp.2020.225  0.526
2019 Koizumi T, Bies R, Suzuki T, Pollock B, Mimura M, Uchida H. Fluctuations in hallucinatory experiences within a day in relation to dopamine D2 receptor blockade with antipsychotics in patients with schizophrenia European Neuropsychopharmacology. 29: S134-S135. DOI: 10.1016/j.euroneuro.2018.11.246  0.525
2017 Caravaggio F, Fervaha G, Iwata Y, Plitman E, Chung JK, Nakajima S, Mar W, Gerretsen P, Kim J, Chakravarty MM, Mulsant B, Pollock B, Mamo D, Remington G, Graff-Guerrero A. Amotivation is associated with smaller ventral striatum volumes in older patients with schizophrenia. International Journal of Geriatric Psychiatry. PMID 29110353 DOI: 10.1002/Gps.4818  0.337
2016 Sakurai H, Suzuki T, Bies RR, Pollock BG, Mimura M, Kapur S, Uchida H. Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial. The Journal of Clinical Psychiatry. 77: 1381-1390. PMID 27788310 DOI: 10.4088/JCP.15m10490  0.546
2016 Ho T, Pollock BG, Mulsant BH, Schantz O, Devanand DP, Mintzer JE, Porsteinsson AP, Schneider LS, Weintraub D, Yesavage J, Drye LT, Munro CA, Shade DM, Lyketsos C, Bies R. R-and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation. British Journal of Clinical Pharmacology. PMID 27145364 DOI: 10.1111/Bcp.12997  0.491
2016 Davies SJ, Mulsant BH, Flint AJ, Meyers BS, Rothschild AJ, Whyte EM, Kirshner MM, Sorisio D, Pollock BG, Bies RR. SSRI-antipsychotic combination in psychotic depression: sertraline pharmacokinetics in the presence of olanzapine, a brief report from the STOP-PD study. Human Psychopharmacology. PMID 27060853 DOI: 10.1002/hup.2532  0.549
2015 Akil A, Bies RR, Pollock BG, Avramopoulos D, Devanand DP, Mintzer JE, Porsteinsson AP, Schneider LS, Weintraub D, Yesavage J, Shade DM, Lyketsos CG. A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitation. Journal of Pharmacokinetics and Pharmacodynamics. PMID 26611790 DOI: 10.1007/S10928-015-9457-6  0.518
2015 Tsuboi T, Bies RR, Suzuki T, Takeuchi H, Nakajima S, Graff-Guerrero A, Mamo DC, Caravaggio F, Plitman E, Mimura M, Pollock BG, Uchida H. Predicting Plasma Olanzapine Concentration Following a Change in Dosage: A Population Pharmacokinetic Study. Pharmacopsychiatry. PMID 26506574 DOI: 10.1055/S-0035-1565070  0.561
2015 Nakajima S, Uchida H, Bies RR, Caravaggio F, Suzuki T, Plitman E, Mar W, Gerretsen P, Pollock BG, Mulsant BH, Mamo DC, Graff-Guerrero A. Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial. Schizophrenia Bulletin. PMID 26221049 DOI: 10.1093/Schbul/Sbv106  0.546
2015 Davies SJ, Mulsant BH, Flint AJ, Meyers BS, Rothschild AJ, Whyte EM, Kirshner MM, Sorisio D, Pollock BG, Bies RR. The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD. Clinical Pharmacokinetics. PMID 25971243 DOI: 10.1007/s40262-015-0275-1  0.557
2015 Tsuboi T, Suzuki T, Bies RR, Remington G, Pollock BG, Mimura M, Uchida H. Challenging the need for sustained blockade of dopamine D₂ receptor estimated from antipsychotic plasma levels in the maintenance treatment of schizophrenia: A single-blind, randomized, controlled study. Schizophrenia Research. 164: 149-54. PMID 25864950 DOI: 10.1016/J.Schres.2015.03.025  0.551
2014 Li CH, Stratford RE, Velez de Mendizabal N, Cremers TI, Pollock BG, Mulsant BH, Remington G, Bies RR. Prediction of brain clozapine and norclozapine concentrations in humans from a scaled pharmacokinetic model for rat brain and plasma pharmacokinetics. Journal of Translational Medicine. 12: 203. PMID 25142323 DOI: 10.1186/1479-5876-12-203  0.535
2014 Yoshida K, Bies RR, Suzuki T, Remington G, Pollock BG, Mizuno Y, Mimura M, Uchida H. Tardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data. Schizophrenia Research. 153: 184-8. PMID 24491908 DOI: 10.1016/J.Schres.2014.01.017  0.544
2013 Takeuchi H, Suzuki T, Bies RR, Remington G, Mamo DC, Pollock BG, Mimura M, Uchida H. Estimated dopamine D2 receptor occupancy from plasma concentrations of atypical antipsychotics and subjective experience/drug attitude in schizophrenia: an analysis of the CATIE data. Schizophrenia Research. 150: 373-9. PMID 24028745 DOI: 10.1016/J.Schres.2013.08.033  0.575
2013 Moriguchi S, Bies RR, Remington G, Suzuki T, Mamo DC, Watanabe K, Mimura M, Pollock BG, Uchida H. Estimated dopamine D₂ receptor occupancy and remission in schizophrenia: analysis of the CATIE data. Journal of Clinical Psychopharmacology. 33: 682-5. PMID 23899638 DOI: 10.1097/Jcp.0B013E3182979A0A  0.565
2013 Tsuboi T, Bies RR, Suzuki T, Mamo DC, Pollock BG, Graff-Guerrero A, Mimura M, Uchida H. Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 45: 178-82. PMID 23727135 DOI: 10.1016/j.pnpbp.2013.05.010  0.535
2013 Li CH, Pollock BG, Lyketsos CG, Vaidya V, Drye LT, Kirshner M, Sorisio D, Bies RR. Population pharmacokinetic modeling of sertraline treatment in patients with Alzheimer disease: the DIADS-2 study. Journal of Clinical Pharmacology. 53: 234-9. PMID 23436269 DOI: 10.1177/0091270012445793  0.53
2013 Sakurai H, Bies RR, Stroup ST, Keefe RS, Rajji TK, Suzuki T, Mamo DC, Pollock BG, Watanabe K, Mimura M, Uchida H. Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data. Schizophrenia Bulletin. 39: 564-74. PMID 22290266 DOI: 10.1093/schbul/sbr189  0.547
2012 Wessels AM, Jin Y, Pollock BG, Frank E, Lange AC, Vrijens B, Fagiolini A, Kupfer DJ, Rucci P, Kepple G, Anderton J, Buttenfield J, Bies RR. Adherence to escitalopram treatment in depression: a study of electronically compiled dosing histories in the 'Depression: the search for phenotypes' study. International Clinical Psychopharmacology. 27: 291-7. PMID 22990142 DOI: 10.1097/Yic.0B013E3283597678  0.561
2012 Sherer EA, Sale ME, Pollock BG, Belani CP, Egorin MJ, Ivy PS, Lieberman JA, Manuck SB, Marder SR, Muldoon MF, Scher HI, Solit DB, Bies RR. Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building. Journal of Pharmacokinetics and Pharmacodynamics. 39: 393-414. PMID 22767341 DOI: 10.1007/S10928-012-9258-0  0.485
2012 Uchida H, Mamo DC, Pollock BG, Suzuki T, Tsunoda K, Watanabe K, Mimura M, Bies RR. Predicting plasma concentration of risperidone associated with dosage change: a population pharmacokinetic study. Therapeutic Drug Monitoring. 34: 182-7. PMID 22377743 DOI: 10.1097/FTD.0b013e3182489a6f  0.582
2012 Mizuno Y, Bies RR, Remington G, Mamo DC, Suzuki T, Pollock BG, Tsuboi T, Watanabe K, Mimura M, Uchida H. Dopamine D2 receptor occupancy with risperidone or olanzapine during maintenance treatment of schizophrenia: a cross-sectional study. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 37: 182-7. PMID 22230651 DOI: 10.1016/J.Pnpbp.2011.12.013  0.55
2012 Ismail Z, Wessels AM, Uchida H, Ng W, Mamo DC, Rajji TK, Pollock BG, Mulsant BH, Bies RR. Age and sex impact clozapine plasma concentrations in inpatients and outpatients with schizophrenia. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 20: 53-60. PMID 21422906 DOI: 10.1097/JGP.0b013e3182118318  0.565
2011 Feng Y, Gastonguay MR, Pollock BG, Frank E, Kepple GH, Bies RR. Performance of Cpred/Cobs concentration ratios as a metric reflecting adherence to antidepressant drug therapy. Neuropsychiatric Disease and Treatment. 7: 117-25. PMID 21552314 DOI: 10.2147/Ndt.S15921  0.569
2011 Bigos KL, Bies RR, Pollock BG, Lowy JJ, Zhang F, Weinberger DR. Genetic variation in CYP3A43 explains racial difference in olanzapine clearance. Molecular Psychiatry. 16: 620-5. PMID 21519338 DOI: 10.1038/mp.2011.38  0.622
2011 Wessels AM, Bies RR, Pollock BG, Schneider LS, Lieberman JA, Stroup S, Li CH, Coley K, Kirshner MM, Marder SR. Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study. Journal of Clinical Pharmacology. 51: 1587-91. PMID 21209243 DOI: 10.1177/0091270010387604  0.545
2010 Wessels AM, Pollock BG, Anyama NG, Schneider LS, Lieberman JA, Marder SR, Bies RR. Association of 9-hydroxy risperidone concentrations with risk of switching or discontinuation in the clinical antipsychotic trial of intervention effectiveness-Alzheimer's disease trial. Journal of Clinical Psychopharmacology. 30: 683-7. PMID 21105282 DOI: 10.1097/Jcp.0B013E3181Fa05Bb  0.562
2010 Lenze EJ, Goate AM, Nowotny P, Dixon D, Shi P, Bies RR, Lotrich FK, Rollman BL, Shear MK, Thompson PA, Andreescu C, Pollock BG. Relation of serotonin transporter genetic variation to efficacy of escitalopram for generalized anxiety disorder in older adults. Journal of Clinical Psychopharmacology. 30: 672-7. PMID 21105279 DOI: 10.1097/Jcp.0B013E3181Fc2Bef  0.537
2010 Jin Y, Pollock BG, Coley K, Miller D, Marder SR, Florian J, Schneider L, Lieberman J, Kirshner M, Bies RR. Population pharmacokinetics of perphenazine in schizophrenia patients from CATIE: impact of race and smoking. Journal of Clinical Pharmacology. 50: 73-80. PMID 19843655 DOI: 10.1177/0091270009343694  0.545
2010 Jin Y, Pollock BG, Frank E, Cassano GB, Rucci P, Müller DJ, Kennedy JL, Forgione RN, Kirshner M, Kepple G, Fagiolini A, Kupfer DJ, Bies RR. Effect of age, weight, and CYP2C19 genotype on escitalopram exposure. Journal of Clinical Pharmacology. 50: 62-72. PMID 19841156 DOI: 10.1177/0091270009337946  0.557
2009 Bigos KL, Pollock BG, Stankevich BA, Bies RR. Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review. Gender Medicine. 6: 522-43. PMID 20114004 DOI: 10.1016/j.genm.2009.12.004  0.758
2009 Ng W, Uchida H, Ismail Z, Mamo DC, Rajji TK, Remington G, Sproule B, Pollock BG, Mulsant BH, Bies RR. Clozapine exposure and the impact of smoking and gender: a population pharmacokinetic study. Therapeutic Drug Monitoring. 31: 360-6. PMID 19349931 DOI: 10.1097/Ftd.0B013E31819C7037  0.563
2009 Jin Y, Pollock BG, Frank E, Florian J, Kirshner M, Fagiolini A, Kupfer DJ, Gastonguay MR, Kepple G, Feng Y, Bies RR. The effect of reporting methods for dosing times on the estimation of pharmacokinetic parameters of escitalopram. Journal of Clinical Pharmacology. 49: 176-84. PMID 19179296 DOI: 10.1177/0091270008327538  0.553
2009 Kamarck TW, Haskett RF, Muldoon M, Flory JD, Anderson B, Bies R, Pollock B, Manuck SB. Citalopram intervention for hostility: results of a randomized clinical trial. Journal of Consulting and Clinical Psychology. 77: 174-88. PMID 19170463 DOI: 10.1037/A0014394  0.594
2009 Pollock B, Forsyth C, Bies R. The critical role of clinical pharmacology in geriatric psychopharmacology. Clinical Pharmacology & Therapeutics. 85: 89-93. PMID 19037202 DOI: 10.1038/Clpt.2008.229  0.606
2008 Lenze EJ, Sheffrin M, Driscoll HC, Mulsant BH, Pollock BG, Dew MA, Lotrich F, Devlin B, Bies R, Reynolds CF. Incomplete response in late-life depression: getting to remission. Dialogues in Clinical Neuroscience. 10: 419-30. PMID 19170399  0.55
2008 Feng Y, Pollock BG, Coley K, Marder S, Miller D, Kirshner M, Aravagiri M, Schneider L, Bies RR. Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study. British Journal of Clinical Pharmacology. 66: 629-39. PMID 18771484 DOI: 10.1111/J.1365-2125.2008.03276.X  0.52
2008 Frank E, Cassano GB, Rucci P, Fagiolini A, Maggi L, Kraemer HC, Kupfer DJ, Pollock B, Bies R, Nimgaonkar V, Pilkonis P, Shear MK, Thompson WK, Grochocinski VJ, Scocco P, et al. Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression. Clinical Trials (London, England). 5: 253-61. PMID 18559415 DOI: 10.1177/1740774508091965  0.563
2008 Chew ML, Mulsant BH, Pollock BG, Lehman ME, Greenspan A, Mahmoud RA, Kirshner MA, Sorisio DA, Bies RR, Gharabawi G. Anticholinergic activity of 107 medications commonly used by older adults. Journal of the American Geriatrics Society. 56: 1333-41. PMID 18510583 DOI: 10.1111/j.1532-5415.2008.01737.x  0.538
2008 Bigos KL, Pollock BG, Aizenstein HJ, Fisher PM, Bies RR, Hariri AR. Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 3221-5. PMID 18463627 DOI: 10.1038/Npp.2008.52  0.75
2008 Bigos KL, Pollock BG, Coley KC, Miller DD, Marder SR, Aravagiri M, Kirshner MA, Schneider LS, Bies RR. Sex, race, and smoking impact olanzapine exposure. Journal of Clinical Pharmacology. 48: 157-65. PMID 18199892 DOI: 10.1177/0091270007310385  0.774
2006 Bigos KL, Bies RR, Pollock BG. Population pharmacokinetics in geriatric psychiatry. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 14: 993-1003. PMID 17138806 DOI: 10.1097/01.JGP.0000224330.73063.6c  0.771
2006 Chew ML, Mulsant BH, Pollock BG, Lehman ME, Greenspan A, Kirshner MA, Bies RR, Kapur S, Gharabawi G. A model of anticholinergic activity of atypical antipsychotic medications. Schizophrenia Research. 88: 63-72. PMID 16928430 DOI: 10.1016/j.schres.2006.07.011  0.553
2006 Lotrich FE, Bies RR, Smith GS, Pollock BG. Relevance of assessing drug concentration exposure in pharmacogenetic and imaging studies. Journal of Psychopharmacology (Oxford, England). 20: 33-40. PMID 16785268 DOI: 10.1177/1359786806066044  0.585
2006 Feng Y, Pollock BG, Ferrell RE, Kimak MA, Reynolds CF, Bies RR. Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling. British Journal of Clinical Pharmacology. 61: 558-69. PMID 16669849 DOI: 10.1111/J.1365-2125.2006.02629.X  0.578
2006 Fabian TJ, Schwartzman DS, Ujhelyi MR, Corey SE, Bigos KL, Pollock BG, Kroboth PD. Decreasing pain and anxiety associated with patient-activated atrial shock: a placebo-controlled study of adjunctive sedation with oral triazolam. Journal of Cardiovascular Electrophysiology. 17: 391-5. PMID 16643361 DOI: 10.1111/J.1540-8167.2006.00416.X  0.753
2006 Bies RR, Muldoon MF, Pollock BG, Manuck S, Smith G, Sale ME. A genetic algorithm-based, hybrid machine learning approach to model selection. Journal of Pharmacokinetics and Pharmacodynamics. 33: 195-221. PMID 16565924 DOI: 10.1007/S10928-006-9004-6  0.471
2006 Feng Y, Pollock B, Ferrell R, Kimak M, Reynoldsiii C, Bies R. PI-10CYP2D6 genotype and paroxetine pharmacokinetics in the elderly: A population pharmacokinetics analysis in depressed geriatric subjects Clinical Pharmacology & Therapeutics. 79. DOI: 10.1016/J.Clpt.2005.12.031  0.585
2005 Bies RR, Mulsant BH, Rosen J, Huber KA, Wilson NL, Kirshner MA, Pollock BG. Population pharmacokinetics as a method to detect variable risperidone exposure in patients suffering from dementia with behavioral disturbances. The American Journal of Geriatric Pharmacotherapy. 3: 87-91. PMID 16129385 DOI: 10.1016/j.amjopharm.2005.07.002  0.504
2005 Lotrich FE, Bies R, Muldoon MF, Manuck SB, Smith GS, Pollock BG. Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences. Psychopharmacology. 178: 268-75. PMID 15365685 DOI: 10.1007/S00213-004-2006-4  0.556
2004 Bies RR, Feng Y, Lotrich FE, Kirshner MA, Roose S, Kupfer DJ, Pollock BG. Utility of sparse concentration sampling for citalopram in elderly clinical trial subjects. Journal of Clinical Pharmacology. 44: 1352-9. PMID 15545305 DOI: 10.1177/0091270004269647  0.565
2004 Fabian TJ, Amico JA, Kroboth PD, Mulsant BH, Corey SE, Begley AE, Bensasi SG, Weber E, Dew MA, Reynolds CF, Pollock BG. Paroxetine-induced hyponatremia in older adults: a 12-week prospective study. Archives of Internal Medicine. 164: 327-32. PMID 14769630 DOI: 10.1001/Archinte.164.3.327  0.607
2003 Bies RR, Bigos KL, Pollock BG. Gender differences in the pharmacokinetics and pharmacodynamics of antidepressants. The Journal of Gender-Specific Medicine : Jgsm : the Official Journal of the Partnership For Women's Health At Columbia. 6: 12-20. PMID 14513571  0.755
2003 Fabian TJ, Amico JA, Kroboth PD, Mulsant BH, Reynolds CF, Pollock BG. Paroxetine-induced hyponatremia in the elderly due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Journal of Geriatric Psychiatry and Neurology. 16: 160-4. PMID 12967059 DOI: 10.1177/0891988703255689  0.629
2003 Kroboth PD, Amico JA, Stone RA, Folan M, Frye RF, Kroboth FJ, Bigos KL, Fabian TJ, Linares AM, Pollock BG, Hakala C. Influence of DHEA administration on 24-hour cortisol concentrations. Journal of Clinical Psychopharmacology. 23: 96-9. PMID 12544381 DOI: 10.1097/00004714-200302000-00014  0.765
2003 Bies RR, Lotrich FE, Smith G, Muldoon M, Pollock BG. Pharmacokinetics of citalopram after IV infusion Clinical Pharmacology & Therapeutics. 73: P71-P71. DOI: 10.1016/S0009-9236(03)90620-5  0.517
2002 Bies RR, Gastonguay MR, Coley KC, Kroboth PD, Pollock BG. Evaluating the consistency of pharmacotherapy exposure by use of state-of-the-art techniques. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 10: 696-705. PMID 12427578 DOI: 10.1097/00019442-200211000-00008  0.723
2001 Fabian TJ, Dew MA, Pollock BG, Reynolds CF, Mulsant BH, Butters MA, Zmuda MD, Linares AM, Trottini M, Kroboth PD. Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults. Biological Psychiatry. 50: 767-74. PMID 11720695 DOI: 10.1016/S0006-3223(01)01198-2  0.626
2000 Chengappa KN, Levine J, Gershon S, Mallinger AG, Hardan A, Vagnucci A, Pollock B, Luther J, Buttenfield J, Verfaille S, Kupfer DJ. Inositol as an add-on treatment for bipolar depression. Bipolar Disorders. 2: 47-55. PMID 11254020 DOI: 10.1034/J.1399-5618.2000.020107.X  0.351
2000 Chengappa KN, Pollock BG, Parepally H, Levine J, Kirshner MA, Brar JS, Zoretich RA. Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine. Journal of Clinical Psychopharmacology. 20: 311-6. PMID 10831017 DOI: 10.1097/00004714-200006000-00004  0.37
2000 Frye RF, Kroboth PD, Kroboth FJ, Stone RA, Folan M, Salek FS, Pollock BG, Linares AM, Hakala C. Sex differences in the pharmacokinetics of dehydroepiandrosterone (DHEA) after single- and multiple-dose administration in healthy older adults. The Journal of Clinical Pharmacology. 40: 596-605. DOI: 10.1002/J.1552-4604.2000.Tb05985.X  0.626
1999 Fabian TJ, Kroboth PD, Butters MA, Linares AM, Zmuda M, Mulsant B, Pollock B. ARE DHEA AND/OR DHEA-S CONCENTRATIONS ASSOCIATED WITH REMISSION OF DEPRESSION OR IMPROVEMENTS IN MENTAL STATUS SCORES IN OLDER ADULTS? The American Journal of Geriatric Psychiatry. 7: 46-47. DOI: 10.1097/00019442-199911001-00136  0.618
1996 Miller MD, Paradis CF, Houck PR, Rifai AH, Mazumdar S, Pollock B, Perel JM, Frank E, Reynolds CF. Chronic Medical Illness in Patients With Recurrent Major Depression. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 4: 281-290. PMID 28530965 DOI: 10.1097/00019442-199622440-00002  0.325
1996 Pollock B. Clinical Relevance of Pharmacogenetic Variations for Geriatric Psychopharmacology Drug Information Journal. 30: 669-674. DOI: 10.1177/009286159603000309  0.344
1993 Remington G, Pollock B, Voineskos G, Reed K, Coulter K. Acutely psychotic patients receiving high-dose haloperidol therapy Journal of Clinical Psychopharmacology. 13: 41-45. PMID 8486816 DOI: 10.1097/00004714-199302000-00005  0.356
1991 Jarrett DB, Pollock B, Miewald JM, Kupfer DJ. Acute effect of intravenous clomipramine upon sleep-related hormone secretion in depressed outpatients and healthy control subjects Biological Psychiatry. 29: 3-14. DOI: 10.1016/0006-3223(91)90206-2  0.309
Show low-probability matches.